Infections and management at diagnosis
| | HMIA (n = 31) | IBD (n = 30) | P value |
|---|---|---|---|
| Infections at dx | 4 (13%) | 9 (30%) (2 missing) | P = ns |
| Prophylaxis | Pneumocystis: 11 (35%) | Pneumocystis: 15 (60%) | P = ns |
| Pneumocystis + antifungal: 11 (35%) | Pneumocystis + antifungal: 4 (16%) | ||
| Antifungal: 2 (7%) | Antifungal: 0 | ||
| No: 7 (23%) | No: 6 (24%) (missing data 5) | ||
| Ig replacement at dx | 22 (85%) (missing data 5) | 13 (43%) (missing data 1) | P < 0.05 |
| Admission to ICU | 10 (32%) | 2 (6%) | P < 0.05 |
| | HMIA ( | IBD ( | P value |
|---|---|---|---|
| Infections at dx | 4 (13%) | 9 (30%) (2 missing) | P = ns |
| Prophylaxis | Pneumocystis: 11 (35%) | Pneumocystis: 15 (60%) | P = ns |
| Pneumocystis + antifungal: 11 (35%) | Pneumocystis + antifungal: 4 (16%) | ||
| Antifungal: 2 (7%) | Antifungal: 0 | ||
| No: 7 (23%) | No: 6 (24%) (missing data 5) | ||
| Ig replacement at dx | 22 (85%) (missing data 5) | 13 (43%) (missing data 1) | P < 0.05 |
| Admission to ICU | 10 (32%) | 2 (6%) | P < 0.05 |
Ig, immunoglobulin; dx, diagnosis; ICU, intensive care unit.
Sharing content requires targeting cookies to be enabled. Please update your cookie preferences to use this feature.